VTGN Competitors & Alternatives
Compare VistaGen Therapeutics Inc with similar stocks in the same industry
Biotechnology
VTGN
Main Stock$0.24
Tradestie Score
34
Market Cap
$108.92M
Revenue Growth
0.3%
Analyst Upside
+309.8%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.80
|
$97.42M | - | 44 | Compare |
|
PRLD
Prelude Therapeutics Incorporated
|
$6.63
|
$85.47M | - | 43 | Compare |
|
ENTX
Entera Bio Ltd. Ordinary Shares
|
$3.23
|
$84.52M | - | 45 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$4.63
|
$71.69M | - | 48 | Compare |
|
ARTV
Artiva Biotherapeutics, Inc. Common Stock
|
$10.93
|
$71.32M | - | 47 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$13.66
|
$67.94M | - | 41 | Compare |
|
VTVT
vTv Therapeutics Inc. Class A Common Stock
|
$33.26
|
$62.81M | - | 44 | Compare |
|
OTLK
Outlook Therapeutics, Inc. Common Stock
|
$0.65
|
$46.20M | - | 57 | Compare |
|
TENX
Tenax Therapeutics, Inc.
|
$1.75
|
$34.77M | - | 47 | Compare |
|
XBIO
Xenetic Biosciences, Inc.
|
$3.59
|
$4.78M | - | 30 | Compare |
More VTGN Analysis
Data updated: Aug 23, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry